Sun.Oct 23, 2022

article thumbnail

Future-proof the health of rehab therapy with hybrid care

MedCity News

Technology exists today that enables patients to simply use a smartphone to do their physical therapy exercises and get recommendations from their provider based on objective and subjective data.

Patients 101
article thumbnail

Managing Compliance in an Online World

Verb

Social media has completely changed the landscape of direct sales, especially when it comes to compliance. Not only do you have to worry about the information you distribute, but you are also responsible for what your distributors say about your company online. And that can mean HUGE risks for your entire company.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

3 main challenges that rural health systems face, per Dartmouth Health’s CEO

MedCity News

Rural health systems are met with certain obstacles that their suburban and urban counterparts evade, according to Dr. Joanne Conroy, Dartmouth Health’s president and CEO. Some of these include higher poverty rates and more difficulty attracting employees.

76
article thumbnail

Everything You Need to Know About SalesRabbit (Pros & Cons)

Map My Customers

You may be tired of hearing the old adage “work smarter, not harder” But in the digital business environment that today’s field sales teams are working in, it is still very relevant. If your team is not utilizing the power of sales tools for mapping or optimizing your sales territory mapping efforts, you can quickly get left behind by your competitors.

CRM 59
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Symbiosis Capital, HealthTech Arkansas team up to form clinical trials accelerator

MedCity News

BioAR Trial is a new accelerator that will provide companies a guaranteed clinical trial site at one of the hospitals and health systems partnered with the program. Applications are being accepted for the first cohort of companies, which will begin in April.

article thumbnail

Employee Spotlight: Molly Simpson

InCrowd

What is your role within InCrowd? Marketing Director, InCrowd, Inc. What interested you when deciding to join InCrowd? I’ve worked for InCrowd for almost nine years so it’s been a long time since I thought about this. I remember being really excited about the new technology that was being built and how it could help pharma market insights clients get answers faster.

More Trending

article thumbnail

Is customer orientation a priority for your entire company?

Cesare Ferrari

Today any company , big and small, active in the medical business declares openly that it is customer oriented. I would say that being or stating to be customer oriented or customer centric is both fashionable and necessary. However, as you can imagine there are different levels of being customer oriented, a big difference between saying and doing. And inside the companies, it is possible to have different departments with variable levels of customer orientation.

article thumbnail

Payers could save $13.6B annually by covering medically-tailored meals, study finds

MedCity News

The study found that if certain adults received medically-tailored meals, about 1.6 million hospitalizations would have been avoided, resulting in $38.7 billion saved in healthcare expenditures. Programs to provide these meals would have cost $24.8 billion, leading to $13.6 billion in net savings, according to the report.

Medical 61
article thumbnail

An MSL guide to Veterinarian Meeting Strategy

Celeritas

What is the role of a Medical Sales Liaison (MSL). An MSL is a medically specialized representative for pharmaceutical companies. By outlining the product specifications, advising, and educating, they act as a bridge between pharma companies and their clients. MSLs maintain relationships with clinicians, researchers, and other KOLs in specific therapeutic fields, from biotechnology to medical devices.

article thumbnail

Thoughts on amendments to ISO 10993-7 medical device ethylene oxide sterilization residuals

Pharmaceutical Technology

In January 2022, the United Kingdom adopted ISO 10993-7:2008 / Amd 1:2019 as BS EN ISO 10993-7:2008 / A1:2022 without modification. Prior to the implementation of the revised standard, no obvious consideration was given to patient age when setting the appropriate limits for ethylene oxide residues in medical devices. Arbitrary limits given as milligrams of exposure to residues per device were simply prescribed based on the physical contact time allowed for each category of device.

Medical 40
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Japanese MHLW accepts GSK’s NDA for RSV vaccine

Pharmaceutical Technology

The Japanese Ministry of Health, Labour and Welfare (MHLW) has agreed to review GSK ’s new drug application (NDA) for its respiratory syncytial virus (RSV) vaccine candidate for use in older adults. The proposed indication is for preventing RSV-caused lower respiratory tract diseases (LRTD) in adults aged 60 years and above. GSK made the submission based on the positive interim assessment findings from the multi-country, placebo-controlled, randomised, observer-blind Phase III AReSVi-006 clinica